New blood test may Fine-Tune Anti-Rejection meds for liver transplant patients
NCT ID NCT06063213
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 24 times
Summary
This study is testing a new method to monitor the immune system after a liver transplant. The goal is to see if a personalized approach can help doctors give the right amount of anti-rejection medicine, reducing the risk of rejection or infection. About 40 adult liver transplant recipients will be followed for six months to track episodes of rejection and infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSPLANT COMPLICATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Florida
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.